Reineke Soegiharto
Utrecht University(NL)University Medical Center Utrecht(NL)
Publications by Year
Research Areas
Urticaria and Related Conditions, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Autoimmune Bullous Skin Diseases, Drug-Induced Adverse Reactions, Mast cells and histamine
Most-Cited Works
- → Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation(2024)17 cited
- → Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real‐world data from a large multi‐national UCARE study(2024)14 cited
- → Age and fast initial response predict omalizumab retreatment in chronic urticaria(2023)10 cited
- → Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long‐Term Multicentre Real‐World Study(2025)4 cited
- → Performance of high-dose omalizumab in chronic urticaria is predicted by initial improvement to standard dose(2024)2 cited
- → Clinical profile of idiopathic angioedema based on severity and treatment response is independent of the presence of concomitant wheals(2023)
- → Exploring the Disease Duration of Urticaria and Associated Determinants in Primary Care(2025)
- → Performance of omalizumab in patients with mast cell-mediated angioedema with and without wheals(2026)
- → Prevalence of chronic urticaria and healthcare usage of patients with the condition in primary care: a population-based study in the Netherlands(2023)